Evan Castiglia

Evan joined Thuja Capital as an investment director and partner in early 2023.  Prior to that, he was Partner and Head of European Investments for Philips Ventures, the corporate venture capital group of Philips.  During his tenure, Evan led and managed numerous investments across healthcare sectors, including medical device and digital health, and across investment stages from early to growth.  Before joining Philips Ventures, Evan was the Chief Business Officer of the U.S.-based venture backed precision biology company, RareCyte, which he helped lead from product concept to international commercialization.  Evan holds an M.B.A with Distinction from the University of Oxford.

Mobile: +31 6 1874 7344
Email | View my profile